C12N 15/864
Parvoviral vectors
Official title: Parvoviral vectors {, e.g. parvovirus, densovirus}
C12N15/864 (Parvoviral vectors) appears on 200 US grants and 395 published applications in this corpus.
Search patents in C12N- Granted patents
- 200
- Published applications
- 395
- Assignees
- 183
- Inventors
- 698
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 3 |
| 2008 | 1 | 3 |
| 2009 | 0 | 3 |
| 2010 | 2 | 5 |
| 2011 | 0 | 2 |
| 2012 | 2 | 2 |
| 2013 | 3 | 14 |
| 2014 | 3 | 9 |
| 2015 | 8 | 7 |
| 2016 | 6 | 15 |
| 2017 | 9 | 21 |
| 2018 | 8 | 25 |
| 2019 | 16 | 50 |
| 2020 | 17 | 23 |
| 2021 | 32 | 42 |
| 2022 | 18 | 27 |
| 2023 | 26 | 27 |
| 2024 | 17 | 20 |
| 2025 | 15 | 34 |
| 2026 | 16 | 60 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tissue selective transgene expression28 Jul 2026US 12,692,516 B2Encoded Therapeutics, Inc.
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs16 Jun 2026US 12,655,427 B2Research Institute At Nationwide Children's Hospital
- CA2-IL15 fusion proteins for tunable regulation2 Jun 2026US 12,642,792 B2Obsidian Therapeutics, Inc.
- Virus AAV/IGF2, genetic treatment method and use thereof in protein misfolding-related diseases, such as Huntington's disease2 Jun 2026US 12,642,872 B2Universidad De Chile
- Kinetically controlled methods to prepare concentrated shelf-stable nucleic acid transfection vehicles8 Oct 2026US 2026/0308631 A1The Johns Hopkins University
- Dual aav vectors for treating stargardt disease1 Oct 2026US 2026/0295092 A1Atsena Therapeutics, Inc.
- Aav-epo for treating companion animals1 Oct 2026US 2026/0297149 A1The Trustees of the University of Pennsylvania
- Nannochloropsis-producing viruses and methods and compositions for making the same1 Oct 2026US 2026/0297502 A1Insmed Incorporated
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor91US 8,318,480 B2The Trustees of the University of Pennsylvania · 2012
- CNS targeting AAV vectors and methods of use thereof91US 9,102,949 B2University of Massachusetts · 2015
- Viral vectors for the treatment of diabetes86US 11,085,055 B22021